Grand Island, NY, United States of America

Jeffrey S Stults

USPTO Granted Patents = 35 (Patent Applications = 4)

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 2

Average Co-Inventor Count = 2.4

ph-index = 6

Forward Citations = 118(Granted Patents)

Location History:

Grand Island, NY (US) (1990 - 1997)
Lafayette, IN (US) (2013 - 2017)
West Lafayette, IN (US) (1996 - 2019)

Company Filing History:

21 out of 462

Occidental Chemical Corporation

patents

7 out of 63

Salix Pharmaceuticals, Inc.

patents

4 out of 5

Bionevia Pharmaceuticals, Inc.

Great Lakes Chemical Corporation

patents

6. 1 out of 832,680

Other

patents

Years Active: 1990-2019

Loading Chart...

35 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 10464912 - Choline cocrystal of epalrestat (2019-11-05),

2. 9611234 - Choline cocrystal of epalrestat (2017-04-04),

3. 9546183 - Forms of rifaximin and uses thereof (2017-01-17),

4. 9447056 - Solid forms of epalrestat (2016-09-20),

5. 9273066 - Forms of rifaximin and uses thereof (2016-03-01),

6. 9034892 - Forms of rifaximin and uses thereof (2015-05-19),

7. 8906948 - Choline cocrystal of epalrestat (2014-12-09),

8. 8754098 - Forms of rifaximin and uses thereof (2014-06-17),

9. 8697735 - Solid forms of epalrestat (2014-04-15),

10. 8569326 - Forms of rifaximin and uses thereof (2013-10-29),

11. 8486956 - Forms of rifaximin and uses thereof (2013-07-16),

12. 8067429 - Forms of rifaximin and uses thereof (2011-11-29),

13. 5756798 - Process to prepare aryldiphosphoric esters (1998-05-26),

14. 5675039 - Bis-m-benzotrifluoride compounds (1997-10-07),

15. 5512686 - Method for the purification of dioxydiphthalic anhydride and ester (1996-04-30),

Title: Unveiling the Inventive Journey of Jeffrey S Stults from Grand Island, NY

Introduction:

Jeffrey S Stults, a prolific inventor hailing from Grand Island, NY, has made significant strides in the field of pharmaceutical innovations, holding an impressive total of 35 patents to his name. His groundbreaking work has not only pushed the boundaries of scientific discovery but has also paved the way for advancements in healthcare and medical treatments.

Latest Patents:

Among his most recent patents is the revolutionary "Choline cocrystal of epalrestat", a novel formulation designed to address a myriad of health conditions. This patent showcases Stults' dedication to developing new and effective solutions for treating diabetic complications, homocystinuria, and providing cardioprotection to patients, both diabetic and non-diabetic.

Career Highlights:

Throughout his illustrious career, Jeffrey S Stults has left an indelible mark on the pharmaceutical industry. Having worked with esteemed companies such as Occidental Chemical Corporation and Salix Pharmaceuticals, Inc., Stults has honed his expertise in drug development and formulation, leading to a string of successful patents that have impacted countless lives.

Collaborations:

Stults has collaborated with esteemed colleagues such as Willis T Schwartz and Karen Sue Gushurst, pooling their collective knowledge and skills to drive innovation in the pharmaceutical sector. Together, they have worked tirelessly to bring cutting-edge solutions to the market, further solidifying Stults' reputation as a trailblazer in his field.

Conclusion:

In conclusion, Jeffrey S Stults represents the epitome of an inventive mind, continuously striving to push the boundaries of pharmaceutical research and development. His dedication to creating novel solutions for complex health conditions stands as a testament to his unwavering commitment to improving the lives of individuals globally. As Stults continues his innovative journey, one can only anticipate the groundbreaking discoveries that lie ahead.

This text is generated by artificial intelligence and may not be accurate.